The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis-related spasticity

Brain and Behavior
Elisabeth G Celius, Carlos Vila

Abstract

Driving ability is a key function for the majority of patients with multiple sclerosis (MS) to help maintain daily interactions. Both physical and cognitive disability, as well as treatments, may affect the ability to drive. Spasticity is a common symptom associated with MS, and it may affect driving performance either directly or via the medications used to treat it. In this article, we review the evidence relating the antispasticity medicine, Δ9-tetrahydrocannabinol:cannabidiol (THC:CBD) oromucosal spray (Sativex®), and its potential impact on driving performance. Articles were identified by searching PubMed from 1/1/2000 to 30/6/2017 using a specified list of search terms. The articles identified using these search terms were augmented with relevant references from these papers and other articles known to the authors. The results from THC:CBD oromucosal spray driving studies and real-world registries did not show any evidence of an increase in motor vehicle accidents associated with THC:CBD oromucosal spray. The majority of patients reported an improvement in driving ability after starting THC:CBD oromucosal spray, and it was speculated that this may be related to reduced spasticity and/or better cognitive function. It shoul...Continue Reading

References

Aug 6, 2002·Archives of Physical Medicine and Rehabilitation·Maria T SchultheisJohn Deluca
Oct 9, 2002·Archives of Physical Medicine and Rehabilitation·Renee D ColemanScott R Millis
Oct 30, 2003·Multiple Sclerosis : Clinical and Laboratory Research·A LerdalT Moum
Dec 4, 2003·Accident; Analysis and Prevention·Olaf H DrummerPhilip Swann
Jan 17, 2004·Drug and Alcohol Dependence·J G RamaekersO H Drummer
Feb 4, 2006·The Journal of Head Trauma Rehabilitation·Lisa J RapportRenee Coleman Bryer
Jul 13, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M PugliattiI Milanov
Dec 15, 2006·PharmacoEconomics·N MurphyUNKNOWN Cost of Multiple Sclerosis Study Group
Mar 16, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C CollinUNKNOWN Sativex Spasticity in MS Study Group
Oct 6, 2007·Addiction·Franjo GrotenhermenRob Tunbridge
Jul 9, 2008·Journal of Clinical and Experimental Neuropsychology·Kelly A RyanRobert Lisak
Sep 2, 2008·Archives of Physical Medicine and Rehabilitation·Thomas D MarcotteJody Corey-Bloom
Apr 13, 2010·Accident; Analysis and Prevention·Michael G LennéJennifer R Redman
Mar 3, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A NovotnaUNKNOWN Sativex Spasticity Study Group
Oct 7, 2011·Epidemiologic Reviews·Mu-Chen LiGuohua Li
Nov 28, 2012·European Journal of Clinical Pharmacology·C G StottG W Guy
Dec 12, 2012·Clinical Chemistry·Rebecca L Hartman, Marilyn A Huestis
Jan 24, 2014·International Journal of MS Care·Ilya KisterJoseph Herbert
May 29, 2014·Journal of the International Neuropsychological Society : JINS·Dolors BadenesMiquel Aguilar
Jun 8, 2014·Der Nervenarzt·J Küst, C Dettmers
Sep 12, 2014·Acta Neurologica Scandinavica·M FreidelM Lang
Jul 6, 2015·Archives of Physical Medicine and Rehabilitation·Maud RanchetHannes Devos
Nov 28, 2015·Neurodegenerative Disease Management·Patrick Vermersch
May 11, 2016·Journal of Neurology, Neurosurgery, and Psychiatry·F PattiUNKNOWN SA.FE. study group
Oct 22, 2016·Expert Review of Neurotherapeutics·Catalina CoclituRadu Tanasescu
Dec 1, 2014·Injury Epidemiology·Kristin WongGuohua Li
Nov 23, 2016·Neurodegenerative Disease Management·Peter Flachenecker
Dec 1, 2017·Neurology. Clinical Practice·Stacey S CofieldRuth Ann Marrie

❮ Previous
Next ❯

Citations

Jun 16, 2019·Practical Neurology·Gillian Ingram, Owen R Pearson
Jun 10, 2020·Expert Review of Neurotherapeutics·Yara Dadalti FragosoMiguel Angel Macias
Jul 28, 2020·International Journal of Molecular Sciences·Dongchen AnJan Tytgat
Jun 17, 2020·British Journal of Pain·Stephen Ph Alexander
Jan 3, 2021·Multiple Sclerosis and Related Disorders·Gustavsen SOturai Ab
Mar 31, 2021·Ergonomics·Christopher Mitropoulos-RundusDaniel McGehee
Apr 12, 2021·Current Opinion in Psychology·Eric L Sevigny
Jun 10, 2021·The International Journal on Drug Policy·Daniel PerkinsPaul Dietze
Jun 17, 2021·Arquivos de neuro-psiquiatria·Sonia Maria Dozzi BruckiGilmar Prado
Jul 30, 2021·ImmunoTargets and Therapy·Valeria GiorgiPiercarlo Sarzi-Puttini

❮ Previous
Next ❯

Software Mentioned

MOVE
Sativex

Related Concepts

Related Feeds

Cannabis & Cognition

The effect of cannabis on cognitive functioning is being explored for short and long-term effects. Recent studies have shown conflicting results, with some showing no significant effects and others showing neuropsychological impairment. Discover the latest research on cannabis and cognition here.